# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2339551 | A | Therapeutic index, ratio of CC50 for human C8166 cells to EC50 for HIV-1 3B infected in human C8166 cells | 11 | cell-based format | Scientific Literature | |||
2. | ALA2339552 | A | Cytotoxicity against human C8166 cells assessed as inhibition of cell viability after 3 days by MTT assay | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
3. | ALA2339553 | F | Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of syncytia formation after 3 days | Human immunodeficiency virus 1 | 11 | organism-based format | Scientific Literature | ||
4. | ALA2339554 | F | Antiviral activity against TMV strain U1 infected in compound-pretreated Nicotiana glutinosa leaves assessed as inhibition of viral infection at 20 uM incubated with leaf for 6 hrs prior to viral inoculation | Tobacco mosaic virus | 8 | organism-based format | Scientific Literature | ||
5. | ALA2339555 | F | Antiviral activity against TMV strain U1 infected in Nicotiana glutinosa leaves assessed as decrease in number of local leaf lesions incubated with virus for 30 mins prior to inoculation on leaves measured 3 to 4 days post-viral infection by half-leaf method | Tobacco mosaic virus | 10 | organism-based format | Scientific Literature | ||
6. | ALA2339556 | F | Antiviral activity against TMV strain U1 infected in Nicotiana glutinosa leaves assessed as decrease in number of local leaf lesions at 20 uM incubated with virus for 30 mins prior to inoculation on leaves measured 3 to 4 days post-viral infection by half-leaf method | Tobacco mosaic virus | 10 | organism-based format | Scientific Literature |